assembly biosciences | Home - Assembly Bio : Assembly Bio

Keyword	CPC	PCC	Volume	Score	Length of keyword
assembly biosciences	0.7	0.4	8360	65	20
assembly	0.97	0.8	138	64	8
biosciences	1.35	0.6	3519	29	11

Keyword	CPC	PCC	Volume	Score
assembly biosciences	1.68	0.9	3810	81
assembly biosciences stock	0.48	0.1	376	14
assembly biosciences aktie	0.95	0.4	1177	17
assembly biosciences news	0.29	0.4	7797	97
assembly biosciences nasdaq	1.23	0.2	5595	66
assembly biosciences stocktwits	1.93	0.1	8460	42
assembly biosciences groton ct	0.37	0.2	7162	48
assembly biosciences ir	1.67	0.6	1697	23
assembly biosciences presentation	0.92	0.1	2956	92
assembly biosciences buyout	0.41	0.5	1051	60
assembly biosciences aktie ig	0.78	0.8	1543	26
assembly biosciences stock price	1.83	0.6	3854	34
assembly biosciences corporate presentation	0.57	0.8	7097	42
assembly biosciences inc	0.29	0.2	6933	9
tim myott assembly biosciences	0.87	0.4	8397	92
assembly biosciences address	0.53	0.8	3411	7
assembly biosciences hbv	1.13	0.1	1833	24
assembly biosciences ticker	1.32	0.3	5332	21

Search Results related to assembly biosciences on Search Engine

Home - Assembly Bio : Assembly Bio
assemblybio.com

https://www.assemblybio.com/

WEBAssembly Bio is applying our passion, scientific ingenuity and deep knowledge of virology to pursue novel antivirals with the potential to change the paradigm for the treatment of serious diseases. Our ambitious and compassionate work has the potential to change lives. Discover our pipeline.

DA: 69 PA: 61 MOZ Rank: 23

About - Assembly Bio : Assembly Bio
assemblybio.com

https://www.assemblybio.com/about/

WEBAssembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic clinical candidates capable of improving the lives of millions living with chronic hepatitis B virus (HBV) infection around the world, and research and preclinical programs focused on the discovery of novel antivirals to treat devastating viral diseases, includi...

DA: 78 PA: 42 MOZ Rank: 52

Gilead and Assembly Biosciences Establish Partnership to …
gilead.com

https://www.gilead.com/news-and-press/press-room/press-releases/2023/10/gilead-and-assembly-biosciences-establish-partnership-to-develop-next-generation-therapeutics-for-serious-viral-diseases

WEBOct 17, 2023 · Led by an accomplished team of leaders in virologic drug development, Assembly Bio is committed to improving outcomes for patients struggling with the serious, chronic impacts of herpesvirus, hepatitis B virus (HBV) and hepatitis delta virus (HDV) infections. For more information, visit Assemblybio.com .

DA: 25 PA: 9 MOZ Rank: 24

Investor Relations : Assembly Biosciences, Inc.
assemblybio.com

https://investor.assemblybio.com/

WEBAssembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights. Assembly Biosciences Announces Effective Date of Reverse Stock Split. Assembly Biosciences Provides Anticipated Development Milestones for 2024.

DA: 22 PA: 88 MOZ Rank: 86

Assembly Biosciences, Inc. (ASMB) - Yahoo Finance
yahoo.com

https://finance.yahoo.com/quote/ASMB

WEBAssembly Biosciences, Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States.

DA: 91 PA: 40 MOZ Rank: 23

Assembly Biosciences to Highlight Pipeline Progress in HBV and …
assemblybio.com

https://investor.assemblybio.com/news-releases/news-release-details/assembly-biosciences-highlight-pipeline-progress-hbv-and-hdv

WEBSep 19, 2023 · SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that the company will present new preclinical data from multiple hepatitis B virus (HBV) and …

DA: 3 PA: 37 MOZ Rank: 51

Assembly Biosciences Presents New Data Highlighting Entry …
assemblybio.com

https://investor.assemblybio.com/news-releases/news-release-details/assembly-biosciences-presents-new-data-highlighting-entry

WEBJun 21, 2023 · SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced data from its hepatitis D virus (HDV) and hepatitis B virus (HBV) antiviral pipeline featured in five …

DA: 15 PA: 72 MOZ Rank: 64

Assembly Biosciences Reports Third Quarter 2022 Financial …
assemblybio.com

https://www.assemblybio.com/news/assembly-biosciences-reports-third-quarter-2022-financial-results-and-recent-highlights-and-announces-upcoming-conference-participation/

WEBSOUTH SAN FRANCISCO, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics targeting hepatitis B virus (HBV) and other viral diseases, today announced financial results and recent highlights for the third quarter …

DA: 15 PA: 66 MOZ Rank: 45

Assembly Biosciences Presents New Data Highlighting Viral …
yahoo.com

https://finance.yahoo.com/news/assembly-biosciences-presents-data-highlighting-130000693.html

WEBNov 10, 2023 · SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious...

DA: 6 PA: 81 MOZ Rank: 8

Gilead and Assembly Biosciences Establish Partnership to …
yahoo.com

https://finance.yahoo.com/news/gilead-assembly-biosciences-establish-partnership-110000902.html

WEBOct 17, 2023 · FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif., October 17, 2023 -- ( BUSINESS WIRE )--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology...

DA: 20 PA: 7 MOZ Rank: 59